Antiviral therapy for COVID-2019

Hanik Badriyah Hidayati; Evi Octavia; Cempaka Thursina Srisetyaningrum

doi:10.35975/apic.v25i3.1522

Antiviral therapy for COVID-2019

Hanik Badriyah Hidayati, Evi Octavia, Cempaka Thursina Srisetyaningrum

Faculty of Medicine

Research output: Contribution to journal › Review article › peer-review

1 Citation (Scopus)

Abstract

The whole world is experiencing a global pandemic caused by Coronavirus disease 2019. As the pandemic progresses, there has been much research on antiviral drugs, such as hydroxychloroquin, chloroquine, remdesivir, lopinavir-ritonavir, favipiravir, oseltamivir, and umifenovir. Specific antiviral drugs proven to be effective against SARS-CoV-2 have not been found and approved for the medication of COVID-19. Currently, case detection, infection control, monitoring, prevention, and supportive care are the means focused on the treatment of COVID-19. A large scale research is currently underway to analyze safety and efficacy of antiviral drugs, while trials of the SAR-CoV-2 vaccine are rapidly expanding. This mini review briefly introduces the current antiviral therapy for COVID-19.

Original language	English
Pages (from-to)	387-392
Number of pages	6
Journal	Anaesthesia, Pain and Intensive Care
Volume	25
Issue number	3
DOIs	https://doi.org/10.35975/apic.v25i3.1522
Publication status	Published - 1 Jun 2021

Keywords

COVID-19
Drugs
Key word: Antiviral therapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.35975/apic.v25i3.1522

Cite this

@article{3437a8a634d74167aca69ed4aaaa9227,

title = "Antiviral therapy for COVID-2019",

abstract = "The whole world is experiencing a global pandemic caused by Coronavirus disease 2019. As the pandemic progresses, there has been much research on antiviral drugs, such as hydroxychloroquin, chloroquine, remdesivir, lopinavir-ritonavir, favipiravir, oseltamivir, and umifenovir. Specific antiviral drugs proven to be effective against SARS-CoV-2 have not been found and approved for the medication of COVID-19. Currently, case detection, infection control, monitoring, prevention, and supportive care are the means focused on the treatment of COVID-19. A large scale research is currently underway to analyze safety and efficacy of antiviral drugs, while trials of the SAR-CoV-2 vaccine are rapidly expanding. This mini review briefly introduces the current antiviral therapy for COVID-19.",

keywords = "COVID-19, Drugs, Key word: Antiviral therapy",

author = "Hidayati, {Hanik Badriyah} and Evi Octavia and Srisetyaningrum, {Cempaka Thursina}",

year = "2021",

month = jun,

day = "1",

doi = "10.35975/apic.v25i3.1522",

language = "English",

volume = "25",

pages = "387--392",

journal = "Anaesthesia, Pain and Intensive Care",

issn = "1607-8322",

publisher = "Faculty of Anaesthesia, Pain and Intensive Care, AFMS",

number = "3",

}

TY - JOUR

T1 - Antiviral therapy for COVID-2019

AU - Hidayati, Hanik Badriyah

AU - Octavia, Evi

AU - Srisetyaningrum, Cempaka Thursina

PY - 2021/6/1

Y1 - 2021/6/1

N2 - The whole world is experiencing a global pandemic caused by Coronavirus disease 2019. As the pandemic progresses, there has been much research on antiviral drugs, such as hydroxychloroquin, chloroquine, remdesivir, lopinavir-ritonavir, favipiravir, oseltamivir, and umifenovir. Specific antiviral drugs proven to be effective against SARS-CoV-2 have not been found and approved for the medication of COVID-19. Currently, case detection, infection control, monitoring, prevention, and supportive care are the means focused on the treatment of COVID-19. A large scale research is currently underway to analyze safety and efficacy of antiviral drugs, while trials of the SAR-CoV-2 vaccine are rapidly expanding. This mini review briefly introduces the current antiviral therapy for COVID-19.

AB - The whole world is experiencing a global pandemic caused by Coronavirus disease 2019. As the pandemic progresses, there has been much research on antiviral drugs, such as hydroxychloroquin, chloroquine, remdesivir, lopinavir-ritonavir, favipiravir, oseltamivir, and umifenovir. Specific antiviral drugs proven to be effective against SARS-CoV-2 have not been found and approved for the medication of COVID-19. Currently, case detection, infection control, monitoring, prevention, and supportive care are the means focused on the treatment of COVID-19. A large scale research is currently underway to analyze safety and efficacy of antiviral drugs, while trials of the SAR-CoV-2 vaccine are rapidly expanding. This mini review briefly introduces the current antiviral therapy for COVID-19.

KW - COVID-19

KW - Drugs

KW - Key word: Antiviral therapy

UR - http://www.scopus.com/inward/record.url?scp=85108914786&partnerID=8YFLogxK

U2 - 10.35975/apic.v25i3.1522

DO - 10.35975/apic.v25i3.1522

M3 - Review article

AN - SCOPUS:85108914786

SN - 1607-8322

VL - 25

SP - 387

EP - 392

JO - Anaesthesia, Pain and Intensive Care

JF - Anaesthesia, Pain and Intensive Care

IS - 3

ER -

Antiviral therapy for COVID-2019

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this